Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2009

01.09.2009 | Clinical Trial

Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a five years experience at the European institute of oncology of Milan (EIO)

verfasst von: J. Y. Petit, U. Veronesi, R. Orecchia, P. Rey, S. Martella, F. Didier, G. Viale, P. Veronesi, A. Luini, V. Galimberti, R. Bedolis, M. Rietjens, C. Garusi, F. De Lorenzi, R. Bosco, A. Manconi, G. B. Ivaldi, O. Youssef

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

In order to reduce mutilation, nipple-areola complex (NAC) conservation can be proposed for the treatment of breast cancer when mastectomy is indicated. To reduce the risk of retro areolar recurrence, a novel radiosurgical treatment combining subcutaneous mastectomy with intraoperative radiotherapy (ELIOT) is proposed. One thousand and one nipple sparing mastectomies (NSM) were performed from March 2002 to November 2007 at the European institute of oncology (EIO), for invasive carcinoma in 82% of the patients and in situ carcinoma in 18%. Clinical complications, aesthetic results, oncological and psychological results were recorded. A comparison was performed between the 800 patients who received ELIOT and the 201 who underwent delayed one-shot radiotherapy on the days following the operation. The median follow up time was 20 months (range 1–69) for a follow up performed in 83% of the patients. The NAC necrosed totally in 35 cases (3.5%) and partially in 55 (5.5%) and was removed in 50 (5%). Twenty infections (2%) were observed and 43 (4.3%) prostheses removed. The median rate of the patients for global cosmetic result on a scale ranging from 0 (worst) to 10 (excellent) was 8. Evaluation by the surgeon in charge of the follow-up gave a similar result. Only 15% of the patients reported a partial sensitivity of the NAC. Of the fourteen (1.4%) local recurrences, ten occurred close to the tumour site, all far from the NAC corresponding to the field of radiation. No recurrences were observed in the NAC. In a group of patients characterized by a very close free margin under the areola, no local recurrence was observed. Overall, 36 cases of metastases and 4 deaths were observed. No significant outcome difference was observed between the 800 patients receiving intraoperative radiotherapy (ELIOT) and the 201 patients receiving delayed irradiation.
Literatur
1.
Zurück zum Zitat Veronesi U, Volterrani F, Luini A et al (1990) Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer 26(6):671–673PubMedCrossRef Veronesi U, Volterrani F, Luini A et al (1990) Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer 26(6):671–673PubMedCrossRef
2.
Zurück zum Zitat Carlson GW, Losken A, Moore B et al (2001) Results of immediate breast reconstruction after skin-sparing mastectomy. Ann Plast Surg 46(3):222–228PubMedCrossRef Carlson GW, Losken A, Moore B et al (2001) Results of immediate breast reconstruction after skin-sparing mastectomy. Ann Plast Surg 46(3):222–228PubMedCrossRef
3.
Zurück zum Zitat Carlson GW, Bostwick JRD, Styblo TM et al (1997) Skin-sparing mastectomy oncologic and reconstructive considerations. Ann Surg 225(5):570–575PubMedCrossRef Carlson GW, Bostwick JRD, Styblo TM et al (1997) Skin-sparing mastectomy oncologic and reconstructive considerations. Ann Surg 225(5):570–575PubMedCrossRef
4.
Zurück zum Zitat Peyser PM, Abel JA, Straker VF et al (2000) Ultra conservative skin-sparing “keyhole” mastectomy and immediate breast and areola reconstruction. Ann R Coll Surg Engl 82(4):227–235PubMed Peyser PM, Abel JA, Straker VF et al (2000) Ultra conservative skin-sparing “keyhole” mastectomy and immediate breast and areola reconstruction. Ann R Coll Surg Engl 82(4):227–235PubMed
5.
Zurück zum Zitat Ho CM, Mak CK, Lau Y et al (2003) Skin involvement in invasive breast carcinoma: safety of skin sparing-mastectomy. Ann Surg Oncol 10(2):102–107PubMedCrossRef Ho CM, Mak CK, Lau Y et al (2003) Skin involvement in invasive breast carcinoma: safety of skin sparing-mastectomy. Ann Surg Oncol 10(2):102–107PubMedCrossRef
6.
Zurück zum Zitat Carlson GW, Styblo TM, Lyles RH et al (2003) Local recurrence after skin-sparing mastectomy: tumor biology or surgical conservatism? Ann Surg Oncol 10(2):108–112PubMedCrossRef Carlson GW, Styblo TM, Lyles RH et al (2003) Local recurrence after skin-sparing mastectomy: tumor biology or surgical conservatism? Ann Surg Oncol 10(2):108–112PubMedCrossRef
7.
Zurück zum Zitat Simmons RM, Fish SK, Gayle L et al (1999) Local and distant recurrence rates in skin-sparing mastectomy compared with non-skin-sparing mastectomies. Ann Surg Oncol 6(7):676–678PubMedCrossRef Simmons RM, Fish SK, Gayle L et al (1999) Local and distant recurrence rates in skin-sparing mastectomy compared with non-skin-sparing mastectomies. Ann Surg Oncol 6(7):676–678PubMedCrossRef
8.
Zurück zum Zitat Slavin SA, Schnitt SJ, Duda RB et al (1998) Skin-sparing mastectomy and immediate reconstruction: oncologic risks and aesthetic results in patients with early stage breast cancer. Plast Reconstr Surg 102(1):49–62PubMedCrossRef Slavin SA, Schnitt SJ, Duda RB et al (1998) Skin-sparing mastectomy and immediate reconstruction: oncologic risks and aesthetic results in patients with early stage breast cancer. Plast Reconstr Surg 102(1):49–62PubMedCrossRef
9.
Zurück zum Zitat Kroll SS, Khoo A, Singletary SE et al (1999) Local recurrence risk after skin-sparing and conventional mastectomy: a 6-year follow-up. Plast Reconstr Surg 104(2):421–425PubMedCrossRef Kroll SS, Khoo A, Singletary SE et al (1999) Local recurrence risk after skin-sparing and conventional mastectomy: a 6-year follow-up. Plast Reconstr Surg 104(2):421–425PubMedCrossRef
10.
Zurück zum Zitat Medina-Franco H, Vasconez LO, Fix RJ et al (2002) Factors associated with local recurrence after skin-sparing mastectomy and immediate breast reconstruction for invasive breast cancer. Ann Surg 235(6):814–819PubMedCrossRef Medina-Franco H, Vasconez LO, Fix RJ et al (2002) Factors associated with local recurrence after skin-sparing mastectomy and immediate breast reconstruction for invasive breast cancer. Ann Surg 235(6):814–819PubMedCrossRef
11.
Zurück zum Zitat Beer GM, Varga Z, Budi S et al (2002) Incidence of the superficial fascia and its relevance in skin-sparing mastectomy. Cancer 94(6):1619–1625PubMedCrossRef Beer GM, Varga Z, Budi S et al (2002) Incidence of the superficial fascia and its relevance in skin-sparing mastectomy. Cancer 94(6):1619–1625PubMedCrossRef
12.
Zurück zum Zitat Wellisch DK, Schain WS, Noone RB, Little JWIII (1987) The psychological contribution of nipple addition in breast reconstruction. Plast Reconstr Surg 80(5):699–704PubMedCrossRef Wellisch DK, Schain WS, Noone RB, Little JWIII (1987) The psychological contribution of nipple addition in breast reconstruction. Plast Reconstr Surg 80(5):699–704PubMedCrossRef
13.
Zurück zum Zitat Cense HA, Rutgers EJ, Lopes-Cardozo M, Van Lanschot JJ (2001) Nipple sparing mastectomy in breast cancer: a viable option? Eur J Surg Oncol 6:521–526CrossRef Cense HA, Rutgers EJ, Lopes-Cardozo M, Van Lanschot JJ (2001) Nipple sparing mastectomy in breast cancer: a viable option? Eur J Surg Oncol 6:521–526CrossRef
14.
Zurück zum Zitat Lambert PA, Kolm P, Perry RR (2000) Parameters that predict nipple involvement in breast cancer. J Am Coll Surg 191(4):354–359PubMedCrossRef Lambert PA, Kolm P, Perry RR (2000) Parameters that predict nipple involvement in breast cancer. J Am Coll Surg 191(4):354–359PubMedCrossRef
15.
Zurück zum Zitat Gajdos C, Tartter PI, Bleiweiss IJ (2000) Subareolar breast cancers. Am J Surg 180(3):167–170PubMedCrossRef Gajdos C, Tartter PI, Bleiweiss IJ (2000) Subareolar breast cancers. Am J Surg 180(3):167–170PubMedCrossRef
16.
Zurück zum Zitat Vyas JJ, Chinoy RF, Vaidya JS (1998) Prediction of nipple and areola involvement in breast cancer. Eur J Surg Oncol 24(1):15PubMedCrossRef Vyas JJ, Chinoy RF, Vaidya JS (1998) Prediction of nipple and areola involvement in breast cancer. Eur J Surg Oncol 24(1):15PubMedCrossRef
17.
Zurück zum Zitat Laronga C, Kemp B, Johnston D, Robb GL, Singletary SE (1999) The incidence of occult nipple-areola complex involvement in breast cancer patients receiving a skin sparing mastectomy. Ann Surg Oncol 6:609–613PubMedCrossRef Laronga C, Kemp B, Johnston D, Robb GL, Singletary SE (1999) The incidence of occult nipple-areola complex involvement in breast cancer patients receiving a skin sparing mastectomy. Ann Surg Oncol 6:609–613PubMedCrossRef
18.
Zurück zum Zitat Gerber B, Krause A, Reimer T et al (2003) Skin-sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction is an oncologically safe procedure. Ann Surg 238(1):120–127PubMedCrossRef Gerber B, Krause A, Reimer T et al (2003) Skin-sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction is an oncologically safe procedure. Ann Surg 238(1):120–127PubMedCrossRef
19.
Zurück zum Zitat Merrick HW, Battle JA, Padgett BJ, Dobelbower RR (1997) ELIOT for early breast cancer: a report on long-term results. Front Radiat Ther Oncol 31:126–130PubMedCrossRef Merrick HW, Battle JA, Padgett BJ, Dobelbower RR (1997) ELIOT for early breast cancer: a report on long-term results. Front Radiat Ther Oncol 31:126–130PubMedCrossRef
20.
Zurück zum Zitat Petit JY, Veronesi U, Orecchia R et al (2003) The nipple-sparing mastectomy: early results of a feasibility study of a new application of perioperative radiotherapy (ELIOT) in the treatment of breast cancer when mastectomy is indicated. Tumori 89:288–291PubMed Petit JY, Veronesi U, Orecchia R et al (2003) The nipple-sparing mastectomy: early results of a feasibility study of a new application of perioperative radiotherapy (ELIOT) in the treatment of breast cancer when mastectomy is indicated. Tumori 89:288–291PubMed
21.
Zurück zum Zitat DuBois J-B, Hay M, Gely S, Saint-Aubert B, Rouanet P, Pujol H (1997) ELIOT in breast carcinomas. Front Radiat Ther Oncol 31:131–137PubMedCrossRef DuBois J-B, Hay M, Gely S, Saint-Aubert B, Rouanet P, Pujol H (1997) ELIOT in breast carcinomas. Front Radiat Ther Oncol 31:131–137PubMedCrossRef
22.
Zurück zum Zitat Battle JA, DuBois J-B, Merrick HW, Dobelbower RR (1999) ELIOT for breast cancer. In: Gunderson LL et al (eds) Current clinical oncology: intraoperative irradiation: techniques and results. Humana Press. Inc, New York, pp 521–526 Battle JA, DuBois J-B, Merrick HW, Dobelbower RR (1999) ELIOT for breast cancer. In: Gunderson LL et al (eds) Current clinical oncology: intraoperative irradiation: techniques and results. Humana Press. Inc, New York, pp 521–526
23.
Zurück zum Zitat Veronesi U, Orecchia R, Luini A, Gatti G, Intra M, Veronesi P et al (2001) Focalised intraoperative irradiation after conservative surgery for early stage breast cancer. The breast 10(Suppl 3):84–89 Veronesi U, Orecchia R, Luini A, Gatti G, Intra M, Veronesi P et al (2001) Focalised intraoperative irradiation after conservative surgery for early stage breast cancer. The breast 10(Suppl 3):84–89
24.
Zurück zum Zitat Veronesi U, Orecchia R, Luini A et al (2001) A preliminary report of intraoperative radiotherapy (ELIOT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer 37:2178–2183PubMedCrossRef Veronesi U, Orecchia R, Luini A et al (2001) A preliminary report of intraoperative radiotherapy (ELIOT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer 37:2178–2183PubMedCrossRef
25.
Zurück zum Zitat Benediktsson KP, Perbeck L, Geigant E, Solders G (1997) Touch sensibility in the breast after subcutaneous mastectomy and immediate reconstruction with a prosthesis. Br J Plast Surg 50(6):443–449PubMedCrossRef Benediktsson KP, Perbeck L, Geigant E, Solders G (1997) Touch sensibility in the breast after subcutaneous mastectomy and immediate reconstruction with a prosthesis. Br J Plast Surg 50(6):443–449PubMedCrossRef
26.
Zurück zum Zitat Simmons RM, Brennan M, Christos P et al (2002) Analysis of nipple/areolar involvement with mastectomy: can areola be preserved? Ann Surg Oncol 9(2):165–168PubMedCrossRef Simmons RM, Brennan M, Christos P et al (2002) Analysis of nipple/areolar involvement with mastectomy: can areola be preserved? Ann Surg Oncol 9(2):165–168PubMedCrossRef
27.
Zurück zum Zitat Chagpar AB (2004) Skin-sparing and nipple-sparing mastectomy: preoperative, intraoperative and postoperative considerations. Am Surg 70(5):425–432PubMed Chagpar AB (2004) Skin-sparing and nipple-sparing mastectomy: preoperative, intraoperative and postoperative considerations. Am Surg 70(5):425–432PubMed
28.
Zurück zum Zitat Crowe JP Jr, Kim JA, Yetman R, Bambury J, Patrick RJ, Baynes D (2004) Nipple-sparing mastectomy: technique and results of 54 procedures. Arch Surg 139(2):148–150PubMedCrossRef Crowe JP Jr, Kim JA, Yetman R, Bambury J, Patrick RJ, Baynes D (2004) Nipple-sparing mastectomy: technique and results of 54 procedures. Arch Surg 139(2):148–150PubMedCrossRef
29.
Zurück zum Zitat Simmons RM, Hollenbeck ST, Latrenta GS (2003) Areola-sparing mastectomy with immediate breast reconstruction. Ann Plast Surg 51(6):547–551PubMedCrossRef Simmons RM, Hollenbeck ST, Latrenta GS (2003) Areola-sparing mastectomy with immediate breast reconstruction. Ann Plast Surg 51(6):547–551PubMedCrossRef
Metadaten
Titel
Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a five years experience at the European institute of oncology of Milan (EIO)
verfasst von
J. Y. Petit
U. Veronesi
R. Orecchia
P. Rey
S. Martella
F. Didier
G. Viale
P. Veronesi
A. Luini
V. Galimberti
R. Bedolis
M. Rietjens
C. Garusi
F. De Lorenzi
R. Bosco
A. Manconi
G. B. Ivaldi
O. Youssef
Publikationsdatum
01.09.2009
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2009
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-008-0304-y

Weitere Artikel der Ausgabe 2/2009

Breast Cancer Research and Treatment 2/2009 Zur Ausgabe

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.